Unlock instant, AI-driven research and patent intelligence for your innovation.

Etoposide self-microemulsion preparation as well as preparation method and application thereof

A technology of poside self-microemulsion and etoposide, applied in the field of etoposide self-microemulsion preparations and its preparation, can solve the problems of only 50% bioavailability and large individual differences

Inactive Publication Date: 2014-01-22
TIANJIN INSTITUTE OF PHARMA RESEARCH
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Oral administration of etoposide soft capsules can improve the curative effect to a certain extent, but the bioavailability is only 50%, and there are large individual differences

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Etoposide self-microemulsion preparation as well as preparation method and application thereof
  • Etoposide self-microemulsion preparation as well as preparation method and application thereof
  • Etoposide self-microemulsion preparation as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Use Capryol 90 as the oil phase, RH40 (Cremophor RH40) as the emulsifier, and HP (Transcutol HP) as the co-emulsifier. Mix the emulsifier and co-emulsifier evenly in the weight ratio of 2:1, 1:1, 1:2, and then mix it with the oil phase in the weight ratio of 1:9, 2:8, 3:7, 4:6, 5:5 , 6:4, 7:3, 8:2, 9:1 mixed at 50r·min -1 Drop into water preheated to 37°C while stirring, and observe the state of microemulsion. Record the changes and status of the mixing system in different proportions, and limit the proportion of emulsifier to ≤40%, the proportion of co-emulsifier to more than 40%, and the proportion of oil phase to between 10% and 30%, and draw these proportion data Ternary phase diagram, select the effective area of ​​the blank self-microemulsion and the effective area of ​​etoposide self-microemulsion, see figure 1 Middle shaded part.

[0022] from figure 1 It can be seen from Figure B in the figure that the ratio range of the etoposide self-microemulsion prescri...

Embodiment 2

[0024] Etoposide self-microemulsion prescription with etoposide concentration of 20mg / ml (100ml)

[0025]

[0026] Preparation method: dissolve the prescribed amount of etoposide in the prescribed amount of Transcutol HP, add the prescribed amount of Cremophor RH40 and Capryol 90, mix well, and obtain.

[0027] The prepared etoposide self-microemulsion is a colorless uniform transparent liquid. Take the prepared etoposide self-microemulsion, dilute 100 times with water, measure the particle size, and the average particle size is 18.3nm. Take 5ml of etoposide self-microemulsion, at 50r·min -1 Add 10 times the amount of water at 37°C under stirring, and the self-microemulsion stock solution can be completely emulsified within 1 minute, forming a transparent O / W type microemulsion with slightly bluish light, and at 50r·min -1 It remained stable for 8 hours under stirring, and no crystals were precipitated.

Embodiment 3

[0029] Etoposide self-microemulsion prescription with etoposide concentration of 25mg / ml (100ml)

[0030]

[0031] Preparation method: dissolve the prescribed amount of etoposide in the prescribed amount of Transcutol HP, add the prescribed amount of Cremophor RH40 and Capryol 90, mix well, and obtain.

[0032] The prepared etoposide self-microemulsion is a colorless uniform transparent liquid. Take the prepared etoposide self-microemulsion, dilute 100 times with water, measure the particle size, and the average particle size is 18.1nm. Take 5ml of etoposide self-microemulsion, at 50r·min -1 Add 10 times the amount of water at 37°C under stirring, and the self-microemulsion stock solution can be completely emulsified within 1 minute, forming a transparent O / W type microemulsion with slightly bluish light, and at 50r·min -1 It remained stable for 8 hours under stirring, and no crystals were precipitated.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an etoposide self-microemulsion preparation as well as a preparation method and application thereof, and belongs to the technical field of medicine. An etoposide self-microemulsion is prepared by taking etoposide as a medicinal active ingredient through cooperating a suitable emulsifier, an auxiliary emulsifier and a stabilizer.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to an etoposide self-microemulsion preparation and a preparation method and application thereof. Background technique [0002] Etoposide, a sugar metabolite of podophyllotoxin, is a cell cycle-specific antineoplastic drug that acts on DNA topoisomerase II to form a drug-enzyme-DNA stable reversible complex that hinders DNA repair , to play an anti-tumor effect. At different concentrations, etoposide has different effects on cell division. High concentration (≥10 μg / mL) etoposide dissolves cells entering mitosis, while low concentration (0.3-10 μg / mL) inhibits cell division. Enter the prophase of mitosis. Etoposide is mainly used for the treatment of lung cancer, lymphoma, acute leukemia, and testicular cancer, especially for small cell lung cancer with early spread and poor prognosis. It is the most active monomer for the treatment of small cell lun...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/107A61K31/7048A61P35/00
Inventor 尹东东王杏林张俊伟杨志强宋丽明
Owner TIANJIN INSTITUTE OF PHARMA RESEARCH